Human thiamine levels are altered by genetic mutations impacting thiamine transporters: alterations affecting solute carrier family 19-member 2 (SLC19A2) may lead to TRMA, sensorineural hearing loss, hyperglycemia, and diabetes mellitus (DM) [41]. Here, SLC19A2 is linked to thiamine-responsive megaloblastic anemia syndrome.